Accreditation Information

In support of improving patient care, this activity has been planned and implemented by UK HealthCare CECentral and Remedica Medical Education and Publishing, Ltd.. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

This live activity is designated for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Other

UK Healthcare CECentral certifies this activity for 1.50 hours of participation.

Needs Statement

P³ is an innovative, global educational program designed to improve the management of patients with advanced prostate cancer. Content for the workshop is based around a series of case studies exploring current management challenges, all with a view to help guide optimal benefit–risk-based treatment sequencing and individualize treatment decisions for our patients.

Objectives

Upon completion of this educational activity, participants will be able to:
1. Demonstrate an understanding of clinical practice guidelines for the treatment of patients with advanced prostate cancer
2. Interpret the latest data supporting the use of new agents for advanced prostate cancer
3. Evaluate the differences among new therapies to help guide optimal benefit–risk-based treatment sequencing during the disease course

Target Audience

P3 workshops are for physicians and other healthcare professionals who treat patients with advanced prostate cancer and want to optimize the management of these patients.

Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by the University of Kentucky are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.